Is Relief Therapeutics stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Relief Therapeutics pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid CHF0.0007 per share. Over the last 1 times between 2022 and 2022, Relief Therapeutics has paid CHF0.0007 with an average of CHF0 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Relief Therapeutics 10 years ago, but if you had invested on Monday 18th of January 2021 when the price was CHF126.80, you would have made a loss of CHF-121.30 per share or -95.66%
No, the average daily trading liquidity for Relief Therapeutics is CHF219 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Relief Therapeutics has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Relief Therapeutics to be medium [0.7 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.